KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Change in Acquisitions & Divestments (2016 - 2025)

Eli Lilly (LLY) has disclosed Change in Acquisitions & Divestments for 17 consecutive years, with $132.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments rose 135.71% year-over-year to $132.0 million, compared with a TTM value of $964.0 million through Dec 2025, up 157.75%, and an annual FY2025 reading of $964.0 million, up 157.75% over the prior year.
  • Change in Acquisitions & Divestments was $132.0 million for Q4 2025 at Eli Lilly, down from $556.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $556.1 million in Q3 2025 and bottomed at -$130.2 million in Q4 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $100.7 million, with a median of $69.2 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments plummeted 16375.0% in 2022, then soared 955.81% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $800000.0 in 2021, then tumbled by 16375.0% to -$130.2 million in 2022, then skyrocketed by 124.42% to $31.8 million in 2023, then skyrocketed by 76.1% to $56.0 million in 2024, then skyrocketed by 135.71% to $132.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for LLY at $132.0 million in Q4 2025, $556.1 million in Q3 2025, and $204.3 million in Q2 2025.